BFRI (Biofrontera, Inc.) Rasio Nilai Pasar marang Nilai Buku

Simbol resmi perusahaan biofrontera-us.com (BFRI)

Biofrontera Inc. competes in an aggressive dermatology segment dominated by large corporate behemoths. Revenues are based on the sale of lamps and high-margin gels. The Ameluz ecosystem retains clinics due to strict FDA standards. The current price-to-book ratio illustrates valuation volatility, while the 1.94 value serves as a baseline indicator for analyzing drawdown risks.

BFRI biofrontera-us.com: Nilai Pasar marang Nilai Buku ing interval 04.07.2022 - 27.10.2026

Rincian metrik keuangan lan pasar Biofrontera Inc. (BFRI)

- rega lan prakiraan konsensus rega:
Rega saham biofrontera-us.com|BFRI - Target median analis
- data kapitalisasi pasar:
Nilai pasar Biofrontera Inc|BFRI - Nilai Wutuh Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Biofrontera|BFRI - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku biofrontera-us.com|BFRI - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Biofrontera Inc.|BFRI - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas biofrontera-us.com|BFRI - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Biofrontera Inc
Analisis wiwitan perusahaan:Biofrontera, Inc. - BFRI
Produk asli biofrontera-us.com

The price action of Biofrontera Inc. (BFRI) is reflected in the historical trend of the price-to-book ratio. This indicator determines the control premium by comparing the market value of the business with its net assets. The calculation is based on the ratio of market capitalization to book value. For Biofrontera Inc. (BFRI), this metric serves as an indicator of how effectively ESG standards and energy-efficient technologies are integrated into its capitalization. Excessive growth of this metric signals a risk of overpaying for assets.

Pesaing utama

Krystal Biotech, Inc. - Rasio Kapitalisasi Pasar marang Nilai Buku|APGE (apogeetherapeutics.com) - Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Arcutis Biotherapeutics, Inc. ARQT|Kapitalisasi Pasar marang Aset Bersih Vericel Corp|Oruka Corp (ORKA) - Rasio Kapitalisasi Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku sanaramedtech.com (SMTI)|Rasio Kapitalisasi Pasar marang Nilai Buku DBVT (DBV Technologies)|Solesence Beauty - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Journey Medical Corp. (DERM)|FBRX: Nilai Pasar marang Nilai Buku|EMPG (Empro) - Rasio Nilai Pasar marang Nilai Buku|Sol-Gel Technologies, Ltd. (SLGL) - Rasio Kapitalisasi marang Aset Bersih|AXIL (AXIL Brands Inc) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku medicuspharma.com (MDCX)|Verrica Pharmaceuticals (VRCA) - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku HOTH (hoththerapeutics.com)|Rasio Nilai Pasar marang Nilai Buku VYNE|Sonoma Pharmaceuticals Inc. - Kapitalisasi Pasar marang Nilai Buku|Quoin Pharma - Rasio Nilai Pasar marang Nilai Buku|AZTR - Rasio Kapitalisasi Pasar marang Nilai Buku|Dermata Therapeutics, Inc. - Rasio Kapitalisasi Pasar marang Nilai Buku|ELAB (Elevai Labs Inc) - Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Revance Therapeutics, Inc (RVNC)